Clinical research in patients with acromegaly for the assessment of test product BIM23B065, that will be given to them as repeated subcutaneous injection

Update Il y a 4 ans
Reference: EUCTR2015-003868-37

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the pharmacodynamics of repeated administration of BIM23B065 in reducing growth hormone (GH) in subjects with acromegaly


Inclusion criteria

  • Confirmed diagnosis of acromegaly, with or without a history of pituitary surgery, treatment naïve patients or patients that have received prior treatment for their acromegaly

Links